Literature DB >> 4700483

Inhibition of bone matrix formation, mineralization, and resorption in thyroparathyroidectomized rats.

J Wergedal, M Stauffer, D Baylink, C Rich.   

Abstract

In previous work we found that vitamin D-deficient and also calcium-deficient rats developed hypocalcemia and an impairment of bone formation and mineralization. The present study of thyroparathyroidectomized (TPTX) rats was undertaken to determine the effect of hypocalcemia without secondary hyperparathyroidism. TPTX rats fed a normal diet developed hypocalcemia and hyperphosphatemia in association with impairment of osteoblastic bone matrix formation and of mineralization of newly formed matrix. The serum calcium x phosphorus product was not decreased. The decreased formation was largely due to a reduction in matrix apposition indicating decreased synthetic activity of individual ostcoblasts. In contrast to the above results, when TPTX rats were fed a high-calcium diet to prevent hypocalcemia, no impairment of either formation or mineralization was found. From the results of these two experiments, it is reasonably certain that hypocalcemia was responsible for the inhibition of formation and mineralization. Moreover, based on the magnitude of the changes in serum calcium and bone parameters in TPTX rats, hypocalcemia could have accounted for the inhibition of formation and mineralization in calcium-deficient as well as vitamin D-deficient rats. In TPTX rats the mineralization defect was manifested by decreases in both the rate of osteoid maturation (indicating a delayed onset of mineralization) and the rate of mineralization. A strong correlation (r = 0.95, P < 0.001) was observed between these two rates suggesting a tight coupling of these two aspects of mineralization.TPTX rats also had lower bone resorption rates and higher serum phosphorus levels than sham-operated animals when the normal calcium diet was fed but not when the high-calcium diet was fed. Thus the inhibition of bone resorption in TPTX rats was at least partially prevented by correction of hyperphosphatemia. This is consistent with previous work showing an inverse relationship between serum phosphorus and bone resorption. Accordingly, the depression of bone resorption in TPTX rats was probably due to hyperphosphatemia as well as to hypoparathyroidism.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4700483      PMCID: PMC302359          DOI: 10.1172/JCI107270

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  24 in total

Review 1.  Skeletal renewal and metabolic bone disease.

Authors:  W H Harris; R P Heaney
Journal:  N Engl J Med       Date:  1969-02-06       Impact factor: 91.245

2.  Effect of calcitonin on the rates of bone formation and resorption in the rat.

Authors:  D Baylink; E Morey; C Rich
Journal:  Endocrinology       Date:  1969-02       Impact factor: 4.736

3.  Potassium and milieu intérieur of bone.

Authors:  F Canas; A R Terepka; W F Neuman
Journal:  Am J Physiol       Date:  1969-07

4.  Effect of phosphate, calcium and magnesium on bone resorption and hormonal responses in tissue culture.

Authors:  L G Raisz; I Niemann
Journal:  Endocrinology       Date:  1969-09       Impact factor: 4.736

5.  Rate of recovery from acute hypocalcemia as a measure of calcium homeostatic efficiency in the dog.

Authors:  M Waron; C Rich
Journal:  Endocrinology       Date:  1969-12       Impact factor: 4.736

6.  Thyrocalcitonin, EGTA, and urinary electrolyte excretion.

Authors:  H Rasmussen; C Anast; C Arnaud
Journal:  J Clin Invest       Date:  1967-05       Impact factor: 14.808

7.  Morphologic evidence of osteomalacia in the parathyroidectomized dog.

Authors:  J M Burkhart; J Jowsey
Journal:  Mayo Clin Proc       Date:  1966-10       Impact factor: 7.616

8.  Bone matrix turnover and balance in vitro. I. The effects of parathyroid hormone and thyrocalcitonin.

Authors:  B Flanagan; G Nichols
Journal:  J Clin Invest       Date:  1969-04       Impact factor: 14.808

9.  Enzymes of protein and phosphate catabolism in rat bone. I. Enzyme properties in normal rats.

Authors:  J E Wergedal
Journal:  Calcif Tissue Res       Date:  1969

10.  Ionized calcium in normal serum, ultrafiltrates, and whole blood determined by ion-exchange electrodes.

Authors:  E W Moore
Journal:  J Clin Invest       Date:  1970-02       Impact factor: 14.808

View more
  11 in total

1.  An integrated computational model of the bone microenvironment in bone-metastatic prostate cancer.

Authors:  Arturo Araujo; Leah M Cook; Conor C Lynch; David Basanta
Journal:  Cancer Res       Date:  2014-05-01       Impact factor: 12.701

2.  1,25-Dihydroxycholecalciferol increases bone resorption in thyroparathyroidectomised mice.

Authors:  J J Reynolds; H Pavlovitch; S Balsan
Journal:  Calcif Tissue Res       Date:  1976-12-02

3.  Stimulation of bone formation in vivo by phosphate supplementation.

Authors:  W H Harris; R P Heaney; L A Davis; E H Weinberg; R D Coutts; A L Schiller
Journal:  Calcif Tissue Res       Date:  1976-11-24

4.  Bone mineralization and metabolism of 3H-25-hydroxyvitamin D3 in thyroparathyroidectomized rats treated with parathyroid extract.

Authors:  J I Rader; G A Howard; E Feist; R T Turner; D J Baylink
Journal:  Calcif Tissue Int       Date:  1979-11       Impact factor: 4.333

5.  Spontaneous hypoparathyroidism: clinical, biochemical and radiological features.

Authors:  A Mithal; P S Menon; A C Ammini; M G Karmarkar; M M Ahuja
Journal:  Indian J Pediatr       Date:  1989 Mar-Apr       Impact factor: 1.967

6.  The comparative effects of vitamin d deficiency and ethane-1-hydroxy-1,1-diphosphonate administration on the histology and glycolysis of chick epiphyseal and articular cartilage.

Authors:  S Bisaz; R Schenk; A S Kunin; R G Russell; R Mühlbauer; H Fleisch
Journal:  Calcif Tissue Res       Date:  1975-12-18

7.  Effects of parathyroid hormone on bone of thyroparathyroidectomized rats: an ultrastructural and enzymatic study.

Authors:  S E Weisbrode; C C Capen; L A Nagode
Journal:  Am J Pathol       Date:  1974-06       Impact factor: 4.307

8.  Normal osteoclast number and function in rat pups lacking parathyroid hormone.

Authors:  M Krukowski; A J Kahn
Journal:  Experientia       Date:  1980-07-15

9.  Prolonged treatments with antiresorptive agents and PTH have different effects on bone strength and the degree of mineralization in old estrogen-deficient osteoporotic rats.

Authors:  Zhiqiang Cheng; Wei Yao; Elizabeth A Zimmermann; Cheryl Busse; Robert O Ritchie; Nancy E Lane
Journal:  J Bone Miner Res       Date:  2009-02       Impact factor: 6.741

10.  Vitamin D and hyperparathyroidism: the Lumleian Lecture 1981.

Authors:  S W Stanbury
Journal:  J R Coll Physicians Lond       Date:  1981-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.